Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Anterior uveitis after treatment of hepatitis C with alpha interferon: the recurrence of a previous inflammatory process due to presumed ocular toxocariasis.

Authors:
Eduardo F Damasceno Nadyr A Damasceno

Ocul Immunol Inflamm 2012 Feb;20(1):53-5

Objective: To report a case of recurrent unilateral presumed ocular toxocariasis after treatment of hepatitis C.

Design: Case study.

Methods: Clinical findings, ultrasonography, computed tomography, and serological tests were performed. Once diagnosis was made, effective treatment was administered.

Results: A 46-year-old woman with a long history of decreased unilateral visual acuity presented with anterior uveitis after the use of interferon alpha and ribavirin for treatment of hepatitis C. A biomicroscopic examination revealed active anterior uveitis, with ultrasonography and computed tomography demonstrating a central granuloma due to partially calcified toxocariasis. After treatment with corticosteroids and cycloplegics, the symptoms were alleviated.

Conclusion: immunostimulation could cause a relapse of the inflammatory reaction found in uveitis due to toxocariasis.

Download full-text PDF

Source
http://dx.doi.org/10.3109/09273948.2011.615448DOI Listing
February 2012

Publication Analysis

Top Keywords

treatment hepatitis
12
anterior uveitis
12
ocular toxocariasis
8
computed tomography
8
presumed ocular
8
toxocariasis treatment
8
ultrasonography computed
8
treatment
5
diagnosis effective
4
tomography demonstrating
4
performed diagnosis
4
effective treatment
4
treatment administeredresults
4
administeredresults 46-year-old
4
treatment corticosteroids
4
corticosteroids cycloplegics
4
examination revealed
4
hepatitis alpha
4
uveitis ultrasonography
4
ribavirin treatment
4

Similar Publications

Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings.

Authors:
Michelle T Martin Sonalie Patel Laura Kulik Christine Chan

J Hepatol 2021 Feb 27. Epub 2021 Feb 27.

University of Illinois Hospital and Health Sciences System.

View Article and Full-Text PDF
February 2021
Similar Publications

REDUCTION IN THE POPULATION PREVALENCE OF HCV VIRAEMIA AMONG PEOPLE WHO INJECT DRUGS ASSOCIATED WITH SCALE-UP OF DIRECT-ACTING ANTIVIRAL THERAPY IN COMMUNITY DRUG SERVICES: REAL WORLD DATA.

Authors:
Norah E Palmateer Andrew McAuley John F Dillon Scott McDonald Alan Yeung Shanley Smith Stephen Barclay Peter Hayes Samantha J Shepherd Rory N Gunson David J Goldberg Matthew Hickman Sharon J Hutchinson

Addiction 2021 Mar 2. Epub 2021 Mar 2.

Glasgow Caledonian University, Cowcaddens Road, Glasgow, G4 0BA, UK.

Background And Aims: There has been little empirical evidence to show the 'real world' impact of scaling-up direct-acting antiviral (DAA) treatment among people who inject drugs (PWID) on hepatitis C virus (HCV) viraemia at a population level. We aimed to assess the population impact of rapid DAA scale-up to PWID delivered through community services - including drug treatment, pharmacies, needle exchanges, and prisons - in the Tayside region of Scotland, compared with Greater Glasgow & Clyde (GGC) and the Rest of Scotland (RoS).

Design: Natural experiment, evaluated using data from national biennial surveys of PWID and national clinical data. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.

Authors:
Amel Ben Saad Virginie Vauthier Ágota Tóth Angelika Janaszkiewicz Anne-Marie Durand-Schneider Alix Bruneau Jean-Louis Delaunay Martine Lapalus Elodie Mareux Isabelle Garcin Emmanuel Gonzales Chantal Housset Tounsia Aït-Slimane Emmanuel Jacquemin Florent Di Meo Thomas Falguières

Liver Int 2021 Mar 1. Epub 2021 Mar 1.

Inserm, Université Paris-Saclay, UMR_S 1193, Physiopathogénèse et traitement des maladies du foie, Hepatinov, 91400, France.

Background & Aim: ABCB4 is expressed at the canalicular membrane of hepatocytes. This ATP-binding cassette (ABC) transporter is responsible for the secretion of phosphatidylcholine into bile canaliculi. Missense genetic variations of ABCB4 are correlated with several rare cholestatic liver diseases, the most severe being progressive familial intrahepatic cholestasis type 3 (PFIC3). Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis.

Authors:
Pasquale Piccolo Rosa Ferriero Anna Barbato Sergio Attanasio Marcello Monti Claudia Perna Florie Borel Patrizia Annunziata Annamaria Carissimo Rossella De Cegli Luca Quagliata Luigi M Terracciano Chantal Housset Jeffrey H Teckman Christian Mueller Nicola Brunetti-Pierri

Proc Natl Acad Sci U S A 2021 Mar;118(10)

Telethon Institute of Genetics and Medicine, Pozzuoli, 80078 Naples, Italy;

α1-Antitrypsin (AAT) deficiency is a common genetic disease presenting with lung and liver diseases. AAT deficiency results from pathogenic variants in the gene encoding AAT and the common mutant Z allele of encodes for Z α1-antitrypsin (ATZ), a protein forming hepatotoxic polymers retained in the endoplasmic reticulum of hepatocytes. PiZ mice express the human ATZ and are a valuable model to investigate the human liver disease of AAT deficiency. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Variations in IL-22, IL-27 and IL-35 serum levels in untreated and treated hepatitis C patients.

Authors:
Azam Taghinejad Shaghik Barani Naser Gholijani Farzad Ghandehari Soolmaz Khansalar Morvarid Asadipour Mohammadali Davarpanah Mohammadreza Fattahi Kurosh Kalantar

Eur Cytokine Netw 2020 Dec;31(4):134-139

Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran.

Background: Hepatitis C virus (HCV) is the leading cause of chronic liver diseases including hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. We aimed to assess serum levels of interleukin (IL)-22, IL-27 and IL-35 in patients with hepatitis C and healthy controls to investigate their possible relationship with viral genotypes and liver enzyme levels.

Method: A total of 30 newly diagnosed hepatitis C patients with no history of antiviral therapy and 30 healthy individuals participated in this study. Read More

View Article and Full-Text PDF
December 2020
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap